# Lisata Therapeutics (LSTA) — Earnings

LSTA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lsta/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.49 |
| EPS estimate | −$0.54 |
| EPS surprise | +8.41% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 6, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/320017/000032001725000070/lsta-20250930.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/format/6f2bd46d-20fa-b0a7-ca92-749f0c8c71e0.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 6, 2025 | −$0.54 | −$0.49 | 8.41% | — | — |
| Q2 2025 | Aug 7, 2025 | −$0.65 | −$0.54 | 16.92% | — | $70,000.00 |
| Q1 2025 | May 8, 2025 | −$0.53 | −$0.55 | -3.77% | — | — |
| Q4 2024 | Feb 27, 2025 | −$0.76 | −$0.55 | 27.63% | — | — |
| Q3 2024 | Nov 12, 2024 | −$0.75 | −$0.59 | 21.33% | — | — |
| Q2 2024 | Aug 12, 2024 | −$0.75 | −$0.61 | 18.67% | — | — |
| Q1 2024 | May 9, 2024 | −$0.73 | −$0.65 | 10.34% | — | — |
| Q4 2023 | Feb 29, 2024 | −$0.86 | −$0.66 | 22.81% | — | — |
| Q3 2023 | Nov 2, 2023 | −$0.93 | −$0.65 | 30.11% | — | — |
| Q2 2023 | Aug 14, 2023 | −$0.70 | −$0.50 | 28.57% | — | — |
| Q1 2023 | May 9, 2023 | −$0.81 | −$0.77 | 4.94% | — | — |
| Q4 2022 | Mar 30, 2023 | −$0.96 | −$0.76 | 20.83% | — | — |
| Q3 2022 | Nov 10, 2022 | −$1.28 | −$7.88 | -518.04% | — | — |
| Q2 2022 | Aug 4, 2022 | −$1.73 | −$1.65 | 4.35% | — | — |
| Q1 2022 | May 5, 2022 | −$1.45 | −$1.05 | 27.59% | — | — |
| Q4 2021 | Mar 22, 2022 | −$1.85 | −$1.65 | 10.81% | — | — |
| Q3 2021 | Nov 4, 2021 | −$1.95 | −$1.80 | 7.69% | — | — |
| Q2 2021 | Aug 5, 2021 | −$2.18 | −$1.50 | 31.03% | — | — |
| Q1 2021 | May 6, 2021 | −$1.13 | −$2.85 | -153.33% | $659,000.00 | — |
| Q4 2020 | Feb 25, 2021 | −$3.98 | −$4.20 | -5.66% | — | — |

## Frequently Asked Questions

### When did Lisata Therapeutics (LSTA) last report earnings?

Lisata Therapeutics last reported on Nov 6, 2025, covering fiscal Q3 2025.

### Did LSTA beat earnings estimates?

Yes. Lisata Therapeutics reported EPS of −$0.49 for Q3 2025 against a −$0.54 estimate — a 8.41% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).